Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chandrasekaran, E.V.
Right arrow Articles by Matta, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandrasekaran, E.V.
Right arrow Articles by Matta, K. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2002, Vol. 12, No. 3 153-162
© 2002 Oxford University Press

Biosynthesis of the carbohydrate antigenic determinants, Globo H, blood group H, and Lewis b: a role for prostate cancer cell {alpha}1,2-L-fucosyltransferase

E.V. Chandrasekaran, Ram Chawda, Robert D. Locke, Conrad F. Piskorz and Khushi L. Matta1

Molecular and Cellular Biophysics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

Prostate carcinoma LNCaP cells were unique among several human cancer cell lines which include two other prostate cancer cell lines, PC-3 and DU-145, in expressing {alpha}1,2-L-fucosyltransferase (FT) as an exclusive FT activity. Affinity gel-GDP and Sephacryl S100 HR columns were used for a partial purification of this enzyme from 3.9 x 109 LNCaP cells (~200-fold; 40% yield). The Km value (2.7 mM) for the LacNAc type 2 acceptor was quite similar to the one reported for the cloned blood group H gene-specified {alpha}1,2-FT [Chandrasekaran et al. (1996) Biochemistry 35, 8914–8924]. N-Ethylmaleimide was a potent inhibitor (Ki 12.5 µM). The enzyme showed four-fold acceptor preference for the LacNAc type 2 unit in comparison to the T-hapten in mucin core 2 structure. Its main features were similar to those of the cloned enzyme: (1) C-6 sulfation of terminal Gal in the LacNAc unit increased the acceptor efficiency, whereas C-6 sialylation abolished acceptor ability; (2) C-6 sulfation of GlcNAc in LacNAc type 2 decreased by 80% the acceptor ability, whereas LacNAc type 1 was unaffected; (3) Lewis x did not serve as an acceptor; (4) the C-4 hydroxyl rather than the C-6 hydroxyl group of the GlcNAc moiety in LacNAc type1 was essential for activity; and (5) the acrylamide copolymer of Galß1,3GlcNAcß-O-Al was the best acceptor among the acrylamide copolymers. Additionally, highly significant biological features of {alpha}1,2FT were identified in the present study. The synthesis of Globo H and Lewis b determinants became evident from the fact that Galß1,3GalNAcß1,3Gal{alpha}-O-Me and Galß1,3(Fuc{alpha}1,4)Glc-NAcß1,3Galß-O-Me served as high-affinity acceptors for this enzyme. Further, D-Fucß1,3Gal-NAcß1,3Gal{alpha}-O-Me was a very efficient acceptor, indicating that the C-6 hydroxyl group of the terminal Gal moiety in Globo H is not essential for the enzyme activity. Thus, the present study was able to demonstrate three different catalytic roles of LNCaP {alpha}1,2-FT, namely, the expressions of blood group H, Lewis b from Lewis a, and Globo H.

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
W.-W. Chang, C. H. Lee, P. Lee, J. Lin, C.-W. Hsu, J.-T. Hung, J.-J. Lin, J.-C. Yu, L.-e. Shao, J. Yu, et al.
Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis
PNAS, August 19, 2008; 105(33): 11667 - 11672.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-Y. Huang, D. A. Thayer, A. Y. Chang, M. D. Best, J. Hoffmann, S. Head, and C.-H. Wong
Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen
PNAS, January 3, 2006; 103(1): 15 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Shu, H. S. Murphy, L. Cooling, and J. A. Shayman
An In Vitro Model of Fabry Disease
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2636 - 2645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. V. Chandrasekaran, S. S. Lakhaman, R. Chawda, C. F. Piskorz, S. Neelamegham, and K. L. Matta
Identification of Physiologically Relevant Substrates for Cloned Gal: 3-O-Sulfotransferases (Gal3STs): DISTINCT HIGH AFFINITY OF Gal3ST-2 and LS180 SULFOTRANSFERASE FOR THE GLOBO H BACKBONE, Gal3ST-3 FOR N-GLYCAN MULTITERMINAL Gal{beta}1,4GlcNAc{beta} UNITS AND 6-SULFOGal{beta}1,4GlcNAc{beta}, AND Gal3ST-4 FOR THE MUCIN CORE-2 TRISACCHARIDE
J. Biol. Chem., March 12, 2004; 279(11): 10032 - 10041.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
R. Peracaula, G. Tabares, L. Royle, D. J. Harvey, R. A. Dwek, P. M. Rudd, and R. de Llorens
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins
Glycobiology, June 1, 2003; 13(6): 457 - 470.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.